| 1. |
Senri Ko, Ryo Yamasaki, Tasuku Okui, Wataru Shiraishi, Mitsuru Watanabe, Yu Hashimoto, Yuko Kobayakawa, Susumu Kusunoki, Jun-ichi Kira, Noriko Isobe., A nationwide epidemiological survey of Facial Onset Sensory and Motor Neuronopathy (FOSMN) in Japan, 34th International symposium on ALS/MND, 2023.12. |
| 2. |
Kazuya Hosokawa, Kishimoto Junji, Yu Taniguchi, Nobutaka Ikeda, Takumi Inami, Satoshi Yasuda, Toyoaki Murohara, Masaru Hatano, Yuichi Tamura, Jun Yamashita, Koichiro Tatsumi, Ichizo Tsujino, Yuko Kobayakawa, Koji Todaka, Keiichi Fukuda, Hiroyuki Tsutsui, Kohtaro Abe PhD, on behalf of KABUKI Investigators., A Multicenter, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients with Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial, American Heart Association 2023, 2023.11. |
| 3. |
Yuko Kobayakawa, Koji Todaka, Yu Hashimoto, Senri Ko, Junji Kishimoto, Ryo Yamasaki, Noriko Isobe, A novel quantitative indicator for disease progression rate in amyotrophic lateral sclerosis, 第63回日本神経学会学術大会, 2022.05. |
| 4. |
Hidenori Ogata, Yuko Kobayakawa, Amina Abdelhadi, Ryo Yamasaki, Atsushi Kawasaki, Chieri Takeuchi, Jun-ichi Kira, Noriko Isobe, Development of standardized ELISA kits for IgG4 anti-neurofascin 155 and anti-contactin-1 antibodies, 2022 PNS Annual Meeting, 2022.05. |
| 5. |
Yuko Kobayakawa, Yu Hashimoto, Senri Ko, Koji Todaka, Junji Kishimoto, Ryo Yamasaki, Noriko Isobe, A new measure of disease severity of amyotrophic lateral sclerosis by conversion of forced vital capacity, Pan-Asian Consortium for Treatment and Research in ALS, 2021.09. |
